Search
for
Sort by
Research 421–450 of 1000+
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Understanding dermatological health challenges in rural communities - An epidemiological study
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study
- Study of platelet‐rich plasma application for skin and plastic surgery in recent 20 years: A bibliometric analysis
- Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
- Erosive Pustular Dermatosis: Delving into Etiopathogenesis and Management
- Cutaneous Manifestations in Patients With COVID-19 Treated at a University Hospital in Southern Brazil
- Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic
- Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Annual Convention in the Time of COVID
- Addressing the average lifespan of skin diseases is critical to good patient care
- Polynucleotides HPT ‐Based Dermal Filler for Skin Rejuvenation: A Prospective Clinical Investigation
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Exploring novel management options for alopecia areata
- Consensus position statement on emerging treatments in dermatology by the Association of Cutaneous Surgeons of India Task Force
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Alopecia Areata
- A Case Report of Discoid Lupus Erythematosus Mimicking Skin Infection
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement